The IOTOD 2015 meeting offered delegates the tools to address the needs of their more complex and challenging patients.
The programme featured leading international experts in the treatment of opioid dependence, who shared their latest data and provided thought-provoking debates on emerging issues. These included recognising and managing prescription opioid dependence, minimising the risks associated with the older patient population, recognising drug–drug interactions, and the future of abuse-deterrent formulations. Cutting edge practical approaches to comorbid drug addiction and psychosocial care in opioid dependence were presented, and the treatment of coexisting hepatitis C was also covered.
Chairs
Professor Sharon Walsh
Professor of Behavioral Science and Psychiatry Center on Drug and Alcohol Research, University of Kentucky
Lexington, KY, USA
Professor Robert Ali
Director, Community Based Treatment Interventions, Drug & Alcohol Services South Australia
Australia
John Marsden
Professor of Addiction Psychology, Addictions Department, King’s College London
London, UK
Speakers
Dr Linda Harris
Chief Executive and Clinical Director of Spectrum Community Health
UK
Professor Seddon Savage
Director, Dartmouth Center on Addiction Recovery and Education
New Hampshire, USA
Professor Elinore McCance-Katz
Professor of Psychiatry, University of California San Francisco
USA
Professor Roy Robertson
General Practitioner (GP), Edinburgh, and Professor of Addiction Medicine, Centre for Population Health Sciences, University of Edinburgh
Edinburgh, UK
Dr Ed Day
Senior Lecturer, National Addiction Centre, King’s College London & Consultant in Addiction Psychiatry, Solihull Integrated Addiction Service
London, UK
Dr Michelle Lofwall
Associate Professor of Psychiatry and Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky
Lexington, KY, USA
Marc Auriacombe
Professor of Psychiatry and Addiction Medicine, University of Bordeaux
Bordeaux, France
Professor Robert West
Professor of Health Psychology and Director of Tobacco Studies, University College London
London, UK
Professor Michael Soyka
Medical Director, Psychiatric Hospital Meiringen
Meiringen, Switzerland
